The global dengue diagnostics and treatment market market is anticipated to grow at a significant CAGR of 5.5% during the forecast period. The key driver in the degue dignostic treatnmet market is the number of cases of dengue are growing rapidly during the past few years. Major regions of the world that are affected by dengue are Africa, the Americas, the Eastern Mediterranean, Southeast Asia and the Western Pacific. According to WHO, dengue affects about 50-100 million people worldwide, annually. Dengue viruses and the virus that causes COVID-19 virus has similar symptoms in the early stages. Most of the people are getting confuse it to be degue and ad tested for dengue. According to the Journal of Medical Virology in March 2021, denguse cases has been increasing at a fastes peace therfore it is required for urgent public policies. Rrestraints in the market is rapid urbanization, lack of sanitation, increases in international trade and mobility of population. Opporunities necessity of dengue treatment in urban areas and the strategic initiatives by market players are creating new opportunities in the dengue treatment market

Impact of COVID-19 Pandemic on Global Dengue Diagnostics & Treatment Market

The immature density of Aedes mosquitoes drastically increased during the COVID-19 lockdown due to paused vector control programs, which has led to increased dengue incidence. During the lockdowns, when human movement is limited to and around own homes, perversely, human–vector contact may be enhanced, resulting in an increased risk of exposure and virus transmission. Moreover, according to a report published by the Directorate of National Vector Borne Disease Control Program 2019, a total of 67,377 cases of dengue and 48 deaths due to the vector-borne disease.

Segmental Outlook 

The global dengue diagnostics & treatment market is segmented based on the testing type, treatment and end-users. Based on the testing type, the market is segmented into ELISA-based tests, RT-PCR based test,  dengue IgG/IgM rapid test,  and others. The other testing type includes serologic and tissue tests. Further, based on the end users, the market is sub-segmented into the hospitals & clinics and diagnostics center. The above-mentioned segments can be customized as per the requirements.  From the end-user segment hospital is dominating in the dengue diagnostic treatment market.

Global Dengue Diagnostics & Treatment  Market Share by Testing Type, 2020 (%)

The ELISA-based Testing is the Most Common Testing Type in the Global Dengue Diagnostics & Treatment Market

The most widely used method for diagnosing dengue is an enzyme-linked immunosorbent assay (ELISA) which measures anti-DENV IgM or IgG antibodies in patient serum. The early diagnosis and management of dengue help to reduce the morbidity and mortality rates of severe forms of dengue disease as well as decrease the risk of wider outbreaks.The enzyme-linked immunosorbent assay (ELISA) is capable of detecting NS1 antigens and differentiating among the four dengue virus serotypes(DENV-1, DENV-2, DENV-3, DENV-4). ELISA kits are found to have superior sensitivity when compared to RDTs. Due to their superior performance, ELISAs would be the recommended diagnostic choice when laboratories with trained personnel and equipment are available.

Regional Outlooks

The global dengue diagnostics & treatment market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America).  The market can be analyzed for particular region or country level as per the requirement.

Global Dengue Diagnostics & Treatment   Market Growth, by Region 2021-2027

The Asia-Pacific Region Holds the Prominent Share in the Global Dengue Diagnostics & Treatment Market

The Asia-Pacific is anticipated to lead the global dengue dignostic and treatment market during the forecat period. In 2020, dengue affected several countries, with an increased number of cases in India, Indonesia, Maldives, and among others. According to the article published in 2019 by Qinlong Jing etal, southern China has experienced considerable high frequency of transmission and recurring epidemics of dengue, especially in Guangzhou, which accounts for 69.2% of reported cases in mainland China. The market for dengue testing in the Asia-Pacific is thus expanding at a faster pace on account of the rising incidence of infectious diseases including dengue. Moreover, emerging economies such as India, Pakistan, and Sri Lanka are also focusing on various people awareness initiatives. According to the article published in 2019 by Y Kajimoto, average number of dengue patients in Japan was rported around 274 in 2019. The economic burden of dengue fever and dengue hemorrhagic fever per patient was about USD 2,093 and USD 11,536, respectively in Japan. Thus, considering all the above-mentioned factors, as the number of patients is rising in this region, the testing of the dengue is also expected to rise and boost the growth of the market.

Market Players Outlook

The major companies serving the global dengue diagnostics & treatment market include QuantuMDx Group Ltd., Arkray Inc., Whidiag SAS, Corgenix Medical Corp, Quidel Corp, Ceres Nanosciences Inc., Sansure Biotech Inc., Pictor Ltd., Roche Diagnostics International, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, In December 2018, Merck and Instituto Butantan, Sao Paulo, Brazil announced a collaboration agreement that they will develop a novel vaccine for the dengue virus. They have attained some rights from the National Institute of Allergy and Infectious Disease for the development of live attenuated tetravalent vaccines (LATV).

The Report Covers

• Market value data analysis of 2020 and forecast to 2027.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global dengue diagnostics & treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.